DePut Hip Patient Received $8.3 Million In Jury Decision

A 12-member jury ordered Johnson & Johnson to pay $8.3 million to a man who was injured by a defective hip manufactured by the company’s DePuy orthopedics division. The hip implant is known as Articular Surface Replacement, or A.S.R., represents one of the greatest medical device failures in recent memory.

Traditional hip implants are made with both metal and plastic components and last for about 15 years before a replacement is needed. Johnson & Johnson was one of many medical device manufacturers to market all-metal hip implants as a more effective and durable alternative to metal and plastic implants.

Evidence produced at the trial indicated that the all-metal design of J&J’s ASR hip implants was defective and actually up to seven times more prone to failure than traditional hip implants.

This why the jury decided to give $8.3 million to Loren Kransky, a retired Montana prison guard. Kranksy’s case is one of thousands pending against J&J. It was the first to go to trial because Kranksy is suffering from terminal cancer.

Another case involving DePuy’s ASR hip implant is underway in Chicago. The plaintiff in that case makes similar allegations of being severely injured after her defective hip implant failed.